Kim YI et al. |
Effects of 15-deoxy-∆¹²,¹â´-prostaglandin Jâ‚‚ on the production of IL-8 and the expression of Toll-like receptor 2 in human primary keratinocytes stimulated with lipopolysaccharide. |
2011 |
Mol. Biol. Rep. |
pmid:20174873
|
Chowdhury AA et al. |
15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21699992
|
Yamamoto Y et al. |
15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21683069
|
Wang P et al. |
Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. |
2011 |
PLoS ONE |
pmid:22096605
|
Murata T et al. |
Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22106279
|
Leamy AW et al. |
Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. |
2011 |
Neurosci. Lett. |
pmid:21855605
|
Tanaka A et al. |
Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. |
2011 |
Am. J. Physiol., Cell Physiol. |
pmid:21865589
|
Surh YJ et al. |
15-Deoxy-Δ¹²,¹â´-prostaglandin Jâ‚‚, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. |
2011 |
Biochem. Pharmacol. |
pmid:21843512
|
Bräutigam K et al. |
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. |
2011 |
J. Cancer Res. Clin. Oncol. |
pmid:20878528
|
Tao H and Hajri T |
Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists. |
2011 |
Biochem. Pharmacol. |
pmid:21924248
|
De Nuccio C et al. |
Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. |
2011 |
J. Neuropathol. Exp. Neurol. |
pmid:21937914
|
Song NY et al. |
Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. |
2011 |
Chem. Res. Toxicol. |
pmid:21728338
|
Hardy KD et al. |
Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo. |
2011 |
J. Lipid Res. |
pmid:20944061
|
Wang JJ and Mak OT |
Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGDâ‚‚ metabolite, 15d-PGJâ‚‚. |
2011 |
Cell Biol. Int. |
pmid:21999315
|
Seno T et al. |
15-Deoxy-Δ¹²,¹ⴠprostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice. |
2011 |
PLoS ONE |
pmid:22003398
|
Koharudin LM et al. |
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:20231490
|
Pedersen PJ et al. |
Prostaglandin phospholipid conjugates with unusual biophysical and cytotoxic properties. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20591667
|
Reddy RC and Standiford TJ |
Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. |
2010 |
Am. J. Respir. Crit. Care Med. |
pmid:20634499
|
Diers AR et al. |
Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. |
2010 |
Biochem. J. |
pmid:20536428
|
Rodrigues WF et al. |
15d-PGJ(2) modulates acute immune responses to Trypanosoma cruzi infection. |
2010 |
Mem. Inst. Oswaldo Cruz |
pmid:20428671
|
Zhu F et al. |
Prostaglandin (PG)D(2) and 15-deoxy-Delta(12,14)-PGJ(2), but not PGE(2), mediate shear-induced chondrocyte apoptosis via protein kinase A-dependent regulation of polo-like kinases. |
2010 |
Cell Death Differ. |
pmid:20150912
|
Syed MA et al. |
Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. |
2010 |
Exp. Cell Res. |
pmid:20797396
|
Poncin S et al. |
Oxidative stress: a required condition for thyroid cell proliferation. |
2010 |
Am. J. Pathol. |
pmid:20093493
|
Kar R et al. |
Mitochondrial remodeling following fission inhibition by 15d-PGJ2 involves molecular changes in mitochondrial fusion protein OPA1. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:20678484
|
Byrns MC et al. |
Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. |
2010 |
J. Steroid Biochem. Mol. Biol. |
pmid:20036328
|
Moraes LA et al. |
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation. |
2010 |
J. Thromb. Haemost. |
pmid:20040043
|
Hatanaka M et al. |
15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. |
2010 |
J. Pharmacol. Sci. |
pmid:20424389
|
Zhang F et al. |
Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells. |
2010 |
J. Neuroimmunol. |
pmid:19942298
|
Zorrilla S et al. |
Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization. |
2010 |
Anal. Biochem. |
pmid:20025845
|
Kim NJ et al. |
Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). |
2010 |
J. Org. Chem. |
pmid:20929274
|
Li H et al. |
Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes. |
2010 |
Biochemistry |
pmid:20853849
|
Bancos S et al. |
Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta(12,14)-prostaglandin J(2) requires Nrf2. |
2010 |
Cell. Immunol. |
pmid:20064636
|
Xue J et al. |
Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells. |
2010 |
Biomed. Pharmacother. |
pmid:19880272
|
Pacienza N et al. |
15-deoxy-Delta(12,14)-PGJ(2) induces cell cycle arrest and apoptosis of haematopoietic progenitors. |
2010 |
Br. J. Haematol. |
pmid:19764987
|
Kim SH et al. |
Toluene diisocyanate (TDI) regulates haem oxygenase-1/ferritin expression: implications for toluene diisocyanate-induced asthma. |
2010 |
Clin. Exp. Immunol. |
pmid:20345975
|
Zimmer M et al. |
The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2. |
2010 |
Cancer Res. |
pmid:20354189
|
Koyama M et al. |
Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis. |
2010 |
Clin. Cancer Res. |
pmid:20371690
|
Cho HY et al. |
Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice. |
2010 |
Am. J. Respir. Crit. Care Med. |
pmid:20224069
|
Mo C et al. |
PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway. |
2010 |
Cell. Signal. |
pmid:19922793
|
Toaldo C et al. |
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells. |
2010 |
J. Cell. Mol. Med. |
pmid:19912441
|
Diers AR et al. |
Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. |
2010 |
Biochem. J. |
pmid:19916962
|
Morgenweck J et al. |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. |
2010 |
Neuropharmacology |
pmid:19891980
|
Lin TH et al. |
Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. |
2010 |
J. Cell. Physiol. |
pmid:20020468
|
Hovsepian E et al. |
15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells. |
2010 |
Shock |
pmid:19997048
|
Théoleyre S et al. |
HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:19951697
|
Shim J et al. |
The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells. |
2010 |
Int. J. Oncol. |
pmid:19956851
|
Bach-Ngohou K et al. |
Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12,14-prostaglandin J2. |
2010 |
J. Physiol. (Lond.) |
pmid:20478974
|
Yokoyama Y et al. |
15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells. |
2010 |
Ther Apher Dial |
pmid:20438519
|
Mishra N et al. |
Inhibition of mitochondrial division through covalent modification of Drp1 protein by 15 deoxy-Delta(12,14)-prostaglandin J2. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:20307494
|
Poncin S et al. |
N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro. |
2010 |
Am. J. Pathol. |
pmid:20489149
|